1[1]Stroun M, Anker P, Lyautey J, et al. Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol,1987,23(6)∶707-712.
2[2]Stroun M, Anker P, Maurice P, et al. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology,1989,46(5)∶318-322.
3[3]Chen XQ, Stroun M, Magnenat JL, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med,1996,2(9)∶1033-1035.
4[4]Nawroz H, Koch W, Anker P, et al. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med,1996,2(9)∶1035-1037.
5[5]Esteller M, Sanchez-Cespedes M, Rosell R, et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res,1999,59(1)∶67-70.[published erratum appears in Cancer Res,1999,59(15)∶3853.]
6[6]Sidransky D. Nucleic acid-based methods for detection of cancer. Science,1997,278(5340)∶1054-1059.
7[7]Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res.1977,37(3)∶646-650.
8[8]Shapiro B, Chakrabarty M, Cohn EM, et al. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer,1983,51(11)∶2116-2120.
9[9]Sorenson GD, Pribish M, Valone FH, et al. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomarkers Prev,1994,3(1)∶67-71.
10[10] Jung R, Lubcke C, Wagener C, et al. Reversal of RT-PCR inhibition observed in heparinized clinical specimens. Biotechniques,1997,23(1)∶24,26,28.
